Dolutegravir, Darunavir/Ritonavir and Optimized NRTI Recycling as a Third-line Antiretroviral Regimen in Cambodia
Phase of Trial: Phase II
Latest Information Update: 23 Nov 2018
At a glance
- Drugs Abacavir (Primary) ; Darunavir/ritonavir (Primary) ; Dolutegravir (Primary) ; Lamivudine (Primary) ; Tenofovir (Primary) ; Zidovudine (Primary)
- Indications HIV-1 infections
- Focus Therapeutic Use
- 15 Oct 2018 Planned End Date changed from 1 Sep 2020 to 3 Oct 2020.
- 15 Oct 2018 Planned primary completion date changed from 1 Feb 2020 to 3 Oct 2020.
- 15 Oct 2018 Status changed from not yet recruiting to recruiting.